Minimally invasive surgery is best treatment for early lung cancer

Collaborating to assess the role of stereotactic body radiation therapy in medically operable stage I non-small cell lung cancer

“…We also appreciate the comments in both editorials about the surgical outcomes in our propensity-matched cohort (1,3). Although a 90-day mortality of 0% and 3-year overall survival of 85.7% may be considered by some as "better than expected", other modern studies using VATS lobectomy have shown similar outcomes (4).…”